Elevated levels of IL-17 have been observed in 80% of human sporadic cancer tissues50 and ablation of IL-17 can inhibit the progression of spontaneous intestinal tumorigenesis in ApcMin/+ mice5. This evidence concerns the gene IL17A and cancer.